ORTHOCON® estimates that over 3.5 million patients undergoing surgeries in the United States and Europe each year could benefit from the intraoperative use of HEMASORB.


ORTHOCON® Announces Uninterrupted Availability of HEMASORB Resorbable Hemostatic Bone Putty
August 23, 2012 - Click to Download